|
gptkbp:instanceOf
|
anabolic steroid
synthetic androgen
|
|
gptkbp:ATCCode
|
none
|
|
gptkbp:brand
|
gptkb:Ganabol
gptkb:Ultragan
gptkb:Equipoise
Boldane
|
|
gptkbp:CASNumber
|
13103-34-9
|
|
gptkbp:chemicalFormula
|
C30H44O3
|
|
gptkbp:compatibleWith
|
human use in the United States
|
|
gptkbp:controlledSubstanceSchedule
|
gptkb:Canada
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:derivedFrom
|
testosterone
|
|
gptkbp:effect
|
increases appetite
increases muscle mass
|
|
gptkbp:eliminationHalfLife
|
14 days (intramuscular)
|
|
gptkbp:excretion
|
kidneys
|
|
gptkbp:firstSynthesized
|
1949
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
boldenone undecylenate
|
|
gptkbp:IUPACName
|
(17β)-17-hydroxyandrosta-1,4-dien-3-one undecanoate
|
|
gptkbp:legalStatus
|
prescription only (in some countries)
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
452.7 g/mol
|
|
gptkbp:parent
|
gptkb:boldenone
|
|
gptkbp:prohibits
|
gptkb:World_Anti-Doping_Agency
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:sideEffect
|
acne
voice changes
increased hair growth
oily skin
|
|
gptkbp:synonym
|
1,4-androstadiene-3-one,17β-ol undecanoate
|
|
gptkbp:usedFor
|
treating horses
|
|
gptkbp:usedIn
|
gptkb:veterinary_medicine
|
|
gptkbp:bfsParent
|
gptkb:Equipoise
|
|
gptkbp:bfsLayer
|
6
|